A. Emirian
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 6
-
- Antibiotic Use and Resistance 2
- Co-authors
- Sylvain BrisseGuillaume ArletDominique DecréGeorges OffenstadtJean‐Claude PetitÉric MauryCharlotte VerdetCatherine Eckert
- Journals
- Journal of Medical Microbiology (2 papers)Journal of Clinical Microbiology (1 paper)Diagnostic Microbiology and Infectious Disease (1 paper)FEBS Letters (1 paper)International Journal of Infectious Diseases (1 paper)
- Partner nations
- FranceSwitzerland
In The Last Decade
A. Emirian
13 papers receiving 410 citations
Peers
Comparison fields: 5 of 58
- Molecular Medicine 226
- Applied Microbiology and Biotechnology 41
- Endocrinology 91
- Clinical Biochemistry 58
- Infectious Diseases 157
Countries citing papers authored by A. Emirian
This map shows the geographic impact of A. Emirian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Emirian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Emirian more than expected).
Fields of papers citing papers by A. Emirian
This network shows the impact of papers produced by A. Emirian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Emirian. The network helps show where A. Emirian may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Emirian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 20 | |
| 2 | 2016 | 20 | |
| 3 | 2016 | 13 | |
| 4 | 2015 | 10 | |
| 5 | 2015 | 6 | |
| 6 | 2014 | 96 | |
| 7 | 2014 | 27 | |
| 8 | 2013 | 16 | |
| 9 | 2013 | 4 | |
| 10 | 2013 | 2 | |
| 11 | 2013 | 48 | |
| 12 | 2011 | 138 | |
| 13 | 2009 | 17 |
About A. Emirian
A. Emirian is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry, Endocrinology and Infectious Diseases, having authored 13 papers that have together received 417 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (3 papers), Pneumonia and Respiratory Infections (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Urinary Tract Infections Management (2 papers), Streptococcal Infections and Treatments (2 papers), Antibiotic Use and Resistance (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Molecular Medicine (226 citations), Applied Microbiology and Biotechnology (41 citations), Endocrinology (91 citations), Clinical Biochemistry (58 citations) and Infectious Diseases (157 citations). A. Emirian has collaborated with scholars based in France and Switzerland. Frequent co-authors include Sylvain Brisse, Guillaume Arlet, Dominique Decré, Georges Offenstadt, Jean‐Claude Petit, Éric Maury, Charlotte Verdet, Catherine Eckert, V. Lalande and Jean‐Claude Merle. Their work appears in journals such as Journal of Medical Microbiology, Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease, FEBS Letters and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.